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ExcrEtion-sEcrEtion products and protEasEs from livE Sporothrix schenckii YEast 
phasE. immunological dEtEction and clEavagE of human igg
Daniel DA RosA(1), Elbio GEzuElE(1), luis CAlEGARi(1) & Fernando Goñi(2,3)
suMMARY
Antigenic preparations from Sporothrix schenckii usually involve materials from mixed cultures of yeast and mycelia presenting 
cross-reactions with other deep mycoses. We have standardized pure yeast phase with high viability of the cells suitable to obtain 
specific excretion-secretion products without somatic contaminations. These excretion-secretion products were highly immunogenic 
and did not produce noticeable cross-reactions in either double immunodiffusion or Western blot. The antigenic preparation consists 
mainly of proteins with molecular weights between 40 and 70 kDa, some of them with proteolytic activity in mild acidic conditions. 
We also observed cathepsin-like activity at two days of culture and chymotrypsin-like activity at four days of culture consistent with the 
change in concentration of different secreted proteins. The proteases were able to cleave different subclasses of human IgG suggesting 
a sequential production of antigens and molecules that could interact and interfere with the immune response of the host. 
KEYwoRDs: Sporothrix schenckii; Excretion-secretion product; Human immunoglobulin; Proteases; Yeast phase.
iNTRoDuCTioN
Sporotrichosis, caused by the dimorphic fungus Sporothrix schenckii 
(Ss), is a dermo-hypodermic mycosis exceptionally systemic, manifested 
as a granulomatous chronic infection. Of worldwide distribution its 
frequency varies among different countries15. Because of the saprophytic 
association of Ss and plants, the fungus entry into the body usually 
occurs through trauma or scratches produced by thorns, splinters or even 
contaminated tree bark and timber. Recently, a widespread transmission 
among cats and to humans in Rio de Janeiro, Brazil, has been described27. 
However, in Uruguay its transmission is predominantly tied to the hunt 
of the armadillo (Dasypus hybridus) particularity that shares with the 
northeast of Argentina9,15,26.
Visible skin lesions are characteristic of the acute disease; whereas, the 
subsequent path to chronicity, that involves migration through the lymphatic 
system and interaction with the host immune defenses, is less defined and 
not clearly understood. It has been established that cell mediated immunity 
involving macrophages, monocytes and neutrophils could play an important 
role in the host immune defense; while the presence of specific antibodies 
does not provide protection against a subsequent infection15.
A murine model of disseminated sporotrichosis obtained by 
inoculating animals with Ss peptide-polysaccharide antigens has 
revealed a transient immune depression between the 4th and 6th week 
after infection7. 
The yeast phase of Ss produces various antigens, essentially 
carbohydrates and proteins that could be responsible for such an effect. 
The most prominent antigen is in the peptide-rhamnomannan fraction 
expressed in the cell wall glycopeptides components19. Using Concanavalin 
A three main glycoproteins of 84, 70 and 58 KDa were identified17, its 
sugar components bind collagen type II, fibronectin and laminin18. Other 
fungi have been shown to produce heat shock proteins (HSP) that could be 
locally responsible for the effects on the host immune system12, 24.
Although the antigenic properties of the peptide-rhamnomannan 
fraction are presently useful for serologic and skin tests, cross- reaction 
could occur with other deep mycoses19. Other studies on predominantly 
yeast phase have also described a range of antigenic proteins between 
22 and 70 KDa, including two extra cellular proteinases20. The first one 
named Proteinase I has a chymotrypsin-like behavior and an optimal 
activity at pH 6.0. The second one, Proteinase II, has cathepsin-like 
activity with optimal working activity at pH 3.530.
In this work, we have focus on the production of pure yeast phase 
cultures useful to evaluate the time differential appearance of secreted 
highly specific Ss antigenic proteins with emphasis on proteases that 
could help in interaction with tissues while interfering with the host 
immune response.
MATERiAls AND METHoDs
Production of Sporothrix schenckii antigens: To obtain antigens 
from Sporothrix schenckii (Ss) yeasts we have used the Ss-IH1992 strain. 
This strain was originally isolated in 1991 at the Mycology Section, 
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Instituto de Higiene (Montevideo, Uruguay) from a case of a human 
lymphangitic sporotrichosis. From the many strains obtained from 
human subjects and available in our laboratory, six were tested, i.e., IH 
1992; IH 1993; IH 1994; IH 1995, IH 1463 and IH 2008. Five out of six 
were obtained in Uruguay but strain IH 2008 which was isolated from 
a longshoreman infected after a trauma produced with a timber box in 
Miranda State, Venezuela. The strain was subsequently maintained in 
Sabouraud/glucose/agar (SGA) (Difco) at 28 ºC.
The conversion of the mycelial phase to the yeast phase was obtained 
after culturing in brain heart infusion-glucose-agar 3.7% (BHIGA) 
(Difco). The cultures of Ss mycelial phase fungus with its characteristic 
filaments and conidia were transferred to BHIGA and cultured at 36.5 ºC, 
5% CO2. Every three days the fungus were scrapped and transferred to 
fresh BHIGA. After every passage the rate of conversion was assessed 
in the following manner; an aliquot of the culture was placed on a 
hemocytometer and on each of the five fields yeast were counted on at 
least twenty squares and the presence of filaments and/or conidiae was 
noted. A culture was considered as 100% yeast phase when no filaments 
of conidia were not seen in any one of the squares, the total yeast count 
was at least 500 and there were yeasts on every square of the grid. The 
presence of filaments or conidia in some of the squares accounted for a 
lesser percentage of the yeast phase on the whole culture.
After the yeast phase was established different antigenic extractions 
were performed by the following methodologies: 
Excretion secretion products obtained from live yeasts (ESPAg LY): 
Yeasts from 4 day old cultures in BHIGA were collected by gentle 
scrapping of the culture surface, washed three times in 2 mL of 0.1M 
phosphate-0.9% NaCl pH 7.2 (PBS pH 7.2) centrifuged at 1500xg for 
five minutes and resuspended in PBS pH 7.2 to a final concentration 
of 3x108 yeasts. The samples with more than 97% viable yeasts were 
centrifuged again, the supernatants discarded and only the pellets were 
kept for immediate use. 
Antigens in excretion secretion products derived from live yeasts 
incubated in short term liquid medium (ESPAg SLM): Yeasts were 
cultured for seven days in BHIGA 3.7%, at 36.5 ºC and 5% CO2. Yeasts 
were collected daily by scrapping, resuspended and washed three times 
in 2 mL of PBS pH 7.2, centrifuged at 2000xg for five minutes and the 
supernatant discarded. The pellets with more than 97% viable yeasts 
were resuspended in PBS pH 7.2 (ESPAg-SLM) a final concentration 
of 2x106 yeasts and incubated at 4 ºC for 24 hours. 
The samples with viable cells above 95% were centrifuged at 
2000xg for five minutes and the supernatants aliquoted and stored at 
-70 ºC until use. 
Somatic antigens (SomAg): The Ss yeasts were cultured for four days 
in BHIGA, 36.5 ºC and 5% CO2. Afterwards, the yeasts were collected 
from the surface of the culture with bacteriological ansa, washed three 
times in PBS pH 7.2 and centrifuged at 2000xg for two minutes. The 
pellets with more than 97% viable yeasts were resuspended in 2 mL 
of PBS pH 7.2 to a final concentration of 2x106 yeasts and sonicated 
(Ultrasonic Processor, Cole-Palmer Instrument Co. Illinois) with 50 
bursts of 30 seconds or until no intact yeasts were observed by light 
microscopy (400x). The sonicated material was centrifuged at 3500xg 
for five minutes, and the supernatant was aliquoted and stored at -70 ºC 
until use. 
Viability studies: Aliquots from different yeast preparations were 
centrifuged at 2000xg and the pellets diluted in a freshly made solution 
of 1.44 mg/mL Acridine Orange 1/10 in PBS pH 7.2. The mixture was 
let stand for 15 minutes at room temperature with occasional mixing and 
observed by epifluorescence microscopy (Zeiss, NAG2) with excitation 
lamp of 490 nm and sweeping filter of 520 nm. The percentage of 
fluorescent viable yeasts was determined by counting at least 100 yeasts 
in ten different fields5,13.
Rabbit anti-ss antisera: New Zealand white rabbits were inoculated 
subcutaneously in four different places in the back and thighs with a 
1 mg/mL solution of proteins from the ESPAg SLM of strain IHM 1992, 
according to VAITUKAITIS et al 32.
serological tests: Double immunodiffusion was used to assess 
the presence of specific antibodies against antigens of Ss at different 
stages of the sporotrichosis infection. The human sera used for the 
assays were obtained at the Clinics of the Mycology Section, Instituto 
de Higiene, Montevideo, Uruguay. Twenty five sera were from nodular 
lymphangitic sporotrichosis, five from fixed cutaneous sporotrichosis 
and three from multiple localization sporotrichosis. The controls for 
possible cross-reactions were ten sera from histoplasmosis, five from 
candidiasis, ten from paracoccidioidomycosis, five from leprosy, five 
from tuberculosis and five from Systemic Lupus Erythematousus. To 
be used as negative controls fifteen sera from healthy donors from the 
Public Health Blood Bank were selected; none had detectable antibodies 
to different mycoses.
As positive controls anti-Ss antibodies were produced in rabbits as 
above mentioned, and the same technique was used to obtain antibodies 
in rabbits against whole antigenic extracts from Histoplasma capsulatum 
(strain IHM 1946), Paracoccidioides brasiliensis (strain Pb 339, CIB, 
Medellin, Colombia) and Aspergillus fumigatus (strain IH 1513). All 
produced antisera were aliquoted in 5 mL sealed flasks and kept at 
-20 ºC until use.
Double immunodiffusion test (DD): Approximately 5 mL of 1% 
melted agarose (Sigma) in 0.05 M Tris-HCl pH 8.6 were poured onto 5 
cm by 5 cm Gel-Bond (Pharmacia) slides to obtain a 3 mm thickness of 
gel. The pattern for the DD test consisted of a central well surrounded 
by six wells each of 6 mm in diameter, according to the method of 
POLONELLI & MORACE22,23. The plates were stained using 0.15% 
Coomassie Brilliant Blue in ethanol: acetic acid:H2O 4:2:4 v/v. 
Characterization of the Excretion secretion Products: The protein 
concentration in all preparations was determined by the bicinchoninic 
acid method (BCA) in microtiter plates according to the method of 
REDINBAUGH & TURLEY25. Bovine serum albumin was used as a 
protein standard. 
Polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting: 
SDS-PAGE was performed according to LAEMMLI16 in 12.5% gels. The 
samples of ESPAg SLM and SomAg for immunoblot were diluted 50% 
in sample buffer (0.07 M Tris-HCl pH 6.8, DTT 0.1M, 2% SDS and 
23% glycerol), boiled for two minutes, applied onto the gels and run for 
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three h at 20 mA/gel. After the run the proteins were transferred onto 
nitrocellulose membranes (0.45 µm, Trans-blot, BioRad) using 0.02M 
Tris-0.1M glycine pH 8.3 overnight at 150 mA in the semidry-transblot 
Techware SIGMA, according to TOWBIN et al.29.
Determination of protease activity on EsPAg slM
Gelatin gels: The ESPAg SLM taken at different days from the 
cultures were analyzed on 12.5% polyacrylamide gels containing 0.1% 
gelatin as per DALTON & HEFFERNAN10.
Determination of the enzymatic specificity with synthetic fluorogenic 
substrates: The protease specificity was determined fluorometrically by 
measuring the release of 7-aminomethylcoumarin (NHMec) (Sigma) 
from the following peptide substrates coupled to the NHMec: N-succinyl.
Ala-Ala-Pro-Phe.AMC, N-succinyl.Leu-Leu-Val-Tyr.AMC, NCBZ Gly-
Gly-Arg.AMC, N-succinyl Gly-Pro-Leu-Gly-Pro.AMC, NCBZ-Phe-Arg.
AMC and N-Boc-Val-Leu-Lys.AMC. The different preparations of 
ESPAg SLM from Ss were used at 1 mg/mL of protein in 50 mM citrate 
pH 4.5; the substrate peptides were added to a final 3.6 µM concentration 
in the mixture and incubated at 37 ºC for 60 minutes. The reaction was 
stopped by the addition of 200 µL of 1.7 M acetic acid. The amount of 
fluorogen released was measured in a Sequoia Turner M 450 fluorometer 
(Sequoia Turner, Tokyo, Japan) using an excitement lamp of 360 nm and 
an emission lamp of 430 nm. One arbitrary unit of enzymatic activity 
was defined as the amount that catalyzes the release of 1 µmol of Mec/
min/mg at 37 ºC1.
Digestion of human Immunoglobulin subclasses IgG1 and IgG2: 
Immunoglobulin subclasses IgG1 and IgG2 were purified from human 
myeloma sera by absorption on a protein G column (Pharmacia). The 
purified immunoglobulins were diluted to a final concentration of 
1 mg/mL in the following buffer solutions; 0.1 M citrate pH 3.5, 0.1 M 
acetate pH 4.5, pH 5.6 and 0.1 M PBS pH 7.2. The ESPAg SLM were 
added in a ratio Ig/ESPAg of 1:10 w/w. The mixtures were incubated 
overnight at 4 ºC, 27 ºC and 36.5 ºC.The reactions were stopped by 
the addition of a protease inhibitor cocktail to a final concentration of 
2 mM PMSF, 10 µM E64, 10 µM EDTA and 1 µM Pepstatin A. As control 
were used the immunoglobulins and ESPAg SLM separately and those 
were incubated in equal conditions from the mixtures of digestions. The 
samples were analyzed on 12.5% SDS-PAGE and stained with Coomassie 
Brilliant Blue R 2503.
REsulTs
At least twelve passages were needed to obtain cultures of pure 
yeasts from transformed Sporothrix schenckii mycelial phase of strain 
IH 1992 (Fig. 1a). After the yeast phase was established the IH 1992 
strain attained logarithmic growth in two days, having a maximum 
viability of 97% in the fourth day of culture (Fig.1b). Three other 
strains: IH 1993, IH 1994, and IH 1995 could not attain either 60% 
transformation to yeast phase after more than 15 passages in BHIGA, 
logarithmic growth after five days of culture and a cell viability of 
more than 70% (Fig. 1a)
The two remaining strains, IH 1463 and IH 2008, presented 
logarithmic growth similar to IH 1992 and attained almost 100% 
transformation to yeast phase with 90% of viable cells after four 
days in culture. However, the strain IH 1992 showed not only a better 
transformation and greater cell viability but an unusually high excretion 
of proteins, 215 µg/mL, to the supernatant (Fig. 1b).
 Based on these results we choose to continue using the strain IH 
1992 and to perform the passages at the fourth day of culture.
Antigenic characterization
Double immunodiffusion: Based in the greater cell viability and high 
excretion of proteins of the four days old culture (Fig. 1b), the ESPAgLY 
and ESPAgSLM were used to prove antibody variability among different 
manifestations of the disease (Fig. 2). There were a lesser number of 
precipitation arcs when the sporotrichosis appeared as dermo-hypodermic 
forms, and that number increased in multilocalized forms with cutaneous 
dissemination through the lympho-hematic way. No cross-reactions with 
different mycoses could be observed using live ESPAg LY produced 
in situ in double immunodiffusion (Fig. 2 III, center well a). The same 
pattern of precipitation arcs was observed using ESPAg SLM from four 
days old cultures. However, a preparation of Som Ag showed prominent 
cross-reactions with Histoplasma capsulatum and Paracoccidioides 
brasiliensis sera (Fig. 2 III, center well b).
SDS-PAGE, Gelatin-PAGE and Immunoblot: Figure 3 shows that the 
SomAg from sonicated yeast presents multiple proteic bands in a range 
between 20 and 90 KDa (Fig. 3a, lane 4); whereas a lesser number of 
bands were observed for ESPAg SLM (Fig. 3a, lane 2). All ESPAg SLM 
bands could be ascribed to bands present in the whole yeast but with 
different relative concentrations (Fig. 3a, lanes 2 and 4). Several bands 
were recognized in immunoblot by the serum of patients with cutaneous 
sporotrichosis (Fig. 3a, lane 1). From them, two of the bands, at around 40 
and 70 KDa, apparent molecular weight. appeared as immunodominant 
proteic antigens present in different concentrations, in either the SomAg 
or the ESPAg SLM.
The pure yeast phase of Sporothrix schenckii shed proteic antigens 
from day one. However, some protein bands changed their relative 
concentration along the four days of culture. It is noticeable in Fig. 3a, 
lanes 5 to 8 that whereas the band present around 40 kDa essentially 
did not change its concentration, the one at around 66-70 kDa increased 
its presence conversely to the decrease of the 55-58 kDa band. All this 
Fig. 1 -  a) Conversion in BHIGA of Sporothrix schenckii fungus from mycelial phase to yeast 
phase expressed as percentage of yeast phase on each passage, see materials and methods. 
Strains:  IHM 1992;  IHM 2008;  IHM 1463;  IHM 1995;  IHM 1994;  IHM 1993. 
b) IHM 1992 strain:  Percentage of Ss viable yeasts at different days of culture on BHIGA 
and  protein concentration from the supernatants, determined as µg/mL (ESPAg SLM).
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occurred from days one to four of culture when a maximum excretion 
of proteins maintaining the integrity of the cell - 98% viability - was 
shown (Fig. 1b).
The bands at 40 kDa and 70 kDa were also detected in a Gelatin-
PAGE proving them to be proteases present in different amounts at 
different stages of the yeast development (Fig. 3a, lane 3). 
Enzymatic assays with fluorogenic substrates: The results obtained 
in the Gelatin-PAGE prompted us to determine the type of protease 
activities present in ESPAg SLM and its fluctuation along the four days 
period of culture. The comparative hydrolysis of different NH.Mec-
peptides by ESPAg SLM of two and four days of culture is presented 
in Table 1. There is a consistent hydrolysis over time of a N-Boc-
Val-Leu-Lys.AMC, a plasmin-like activity. On the other hand, there 
is a robust activity at day two of the NCBZ-Phe-Arg.AMC peptide 
compatible with a cathepsin-like activity that decreases by day four. A 
similar but lesser effect was seen on an N-Succinyl-Leu-Leu-Val-Tyr.
AMC substrate that corroborates the cathepsin activity. After four days 
it was noticeable an increased activity on the N-Succinyl-Ala-Ala-
Pro-Phe.AMC and N-Succinyl-Gly-Pro-Leu-Gly-Pro.AMC peptides 
compatible with a chymotrypsin-like activity poorly represented at 
the first day of culture. 
Digestion of IgG subclasses: Because of the cathepsin and 
chymotrypsin-like activities determined by fluorogenic peptides, the 
capacity of ESPAg SLM to cleave host proteins particularly human 
immunoglobulins was tested. The ESPAg SLM from the 4th day of culture 
were incubated with IgG subclasses 1 and 2. Figure 4 shows that after 
24 hours of treatment at 27 °C or 37 °C in 50 mM acetate buffer pH 4.5 
or pH 5.6 a human IgG1 showed a partial cleavage of the heavy chain in 
three fragments of 33, 34 and 46 kDa (Fig. 4a, lane 3 and 4), compared 
with the control of ESPAg SLM and IgG 1 without digesting (Fig. 4a, lane 
1 and 2) . A human IgG2 treated in the same conditions produced heavy 
chain fragments of 29 and 36 kDa (Fig. 4b, lane 9 to 12), compared with 
the control of ESPAg SLM and IgG 1 without digesting (Fig. 4a, lane 1 
and Fig. 4b, lane 8) .
Fig. 2 -  Double immunodiffusion with strain IHM 1992 in the center well. Center well a: 
ExoAg SLY; center well b: SomAg. Numbers 1,8,10: fixed sporotrichosis; 6: lymphocutaneous 
multiple sporotrichosis; 7: hemato-disseminated sporotrichosis; 2: rabbit  antiserum against 
Ss ExoAg SLM Ss six weeks after the first injection; 9: rabbit antiserum against Exo Ag 
SLM two weeks after the first injection; 9´: same as before four weeks after the first injection; 
5,11,12, 17: Normal human serum from blood bank healthy donors, tested negative for 
different mycoses (see M&M); 3,4: lymphocutaneous sporotrichosis; 13 to 16:human sera 
from different mycoses; 13: candidiasis; 14: paracoccidioidomycosis; 15: histoplasmosis; 
16: aspergillosis.
Fig. 3 - Gelatin substrate PAGE, SDS-PAGE and Western blot analysis of ESPAg SLM from Sporothrix schenckii strain IHM 1992. a) Lane 1: Immunoblot using a serum from a patient with 
lymphangitic sporotrichosis; lane 2: CBB R250 stain of the supernatant of ESPAg SLM; lane 3 gelatin gel showing the protease activity from ESPAg SLM; lane 4: CBB R250 stain of the 
supernatant of sonicated Ss yeast (Som Ag); lanes 5 to 8: Ss ESPAg SLM from day 1 to day 4 of culture.
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DisCussioN
Although in recent years we have seen noticeable advances in the 
specific immune diagnosis of many human deep mycoses, it has not been 
the case for human sporotrichosis 4,6,8,21.
In the present study we have stressed the importance of producing 
excretion-secretion products of viable yeast to be used as specific 
biological markers for the disease; and we have proposed a relatively 
easy methodology to obtain these antigenic preparations.
The whole system is based primarily in the transformation and 
maintenance of mycelial phase into a yeast phase. The transformation 
of Ss mycelial phase to pure yeast phase culture was difficult but proved 
to be feasible provided certain characteristics were rigorously kept such 
as the use of BHIGA without additives, 36.5 °C, pH 7.4 and a 5% CO2 
atmosphere. The transformation into pure yeast phase was achieved after 
at least twelve passages for most of the strains (Fig. 1). Once this stage 
was attained the maintenance of the culture with a sustained production 
of yeasts in enough quantities to perform several immune tests was 
routinely done (Fig. 2). 
Contrary to other studies that have used mycelial phase or in the best 
of conditions mixed cultures of mycelia, conidia and yeasts with unknown 
viability21,30; we have developed a system to quantify the percentage of 
yeast phase in any passage until we could label the culture pure in one 
of the species. In order to label the culture as pure yeast phase or 100% 
yeast phase we had to ascertain after examination in a hemocytometer 
that there were yeasts in all fields, we counted at least 500 cells and we 
could not see any conidia or mycelia. In this way we standardized all 
cultures to be compared and obtained reproducible results.
The second important consideration was in the change of the media 
or passages in solid phase as often as needed with special emphasis on 
cell viability. Only cultures with more than 95% of viable cells were used 
to produce ESPAgs (Fig. 1b). This cut-off assured us that only negligible 
amounts of somatic antigens would be present in the preparations, being 
the most important change the absence of cell wall antigens, i.e. complex 
high mannose oligosaccharide chains, probably responsible for the cross-
reactions with other fungi8,19,20,23.
Somatic antigens might not be the only source of contamination; 
in fact, the scrapping from the BHIGA had to be gentle to avoid taking 
culture media proved to have proteases and glycoproteins that could be 
mistaken as fungal contents in certain assays (data not shown). To prevent 
it, the scrapped yeasts from the fourth day of culture were also washed 
a quick few times in PBS before being used for producing the ESPAg. 
This last step was carried out overnight at 4 °C to maintain viability over 
95%. Thus, the methodology allowed us to obtain supernatants of the 
ESPAgs SLM with a protein concentration high enough to be used in 
different assays without further processing (Fig. 1b).
To perform double immunodiffusion tests in agar only viable yeasts 
(ESPAg LY and ESPAg SLM) were used. The newly formed antigens 
without somatic contaminants were produced while on the plates and 
proved to be a useful tool to achieve specificity as it could be seen when 
tested alongside Som Ag against the sera from patients with different 
mycoses (Fig. 2 III, a and b).
The sequential analysis of the secreted proteins in the first four days of 
the cultures showed differential expression of glycoproteins coincidental 
with antigenic changes and diverse protease activities. 
 The offering of different antigens to the immune system is 
accompanied by the production of new antibodies by the host; however, 
this qualitative and quantitative change is not followed by an effective 
clarification of the yeasts from tissues or circulation, and the infection 
typically proceeds to chronicity9,15. 
The antigenic variation may pose a problem for the specific detection 
of Ss. Some of the cell surface antigenic determinants in both yeast 
and mycelial phase appear to be specific for Ss8; however, the cross-
reactions reported in other publications might be attributed to the use of 
sonicated yeasts and the subsequent detection of cell wall antigens like 
the monorhamnosyl rhamnomannans17,19. Here, we have demonstrated 
that by using viable cells producing only secreted Ags we could avoid 
most of the cross-reactions with other fungal infections. 
 The sera from patients carrying a cutaneous form of sporotrichosis 
could detect two major antigens of 70 and 40 kDa in the ESPAgs SLM 
preparations. Immunodominant proteins of similar molecular weights 
were detected by SCOTT & MUCHMORE28 in preparations of sonicated 
yeasts.
Also, the synthesis of more than one protease in yeasts has been 
previously reported for other fungi2,30,33. In our case we have detected in 
ESPAgs SLM at low pHs, at least two distinct protease activities that were 
characterized by fluorogenic substrates. They are in accordance with the 
findings by TSUOBI et al.31 obtained in yeast cultures containing some 
filamentous material.
The sequential variation of the proteolytic activities reported in Table 
1 might help to explain the ability of the fungus to invade tissues of the 
host after the conidia were introduced through even a small trauma. 
HEMPEL & GOODMAN14 have determined that 24 to 48 hours is the 
lapsed time between the conidia invasion and the transformation to 
Fig. 4 - 12.5% SDS-PAGE from the digestion of IgG1 (a) and IgG2 (b) by Sporothrix schenckii 
exoantigens. All samples were reduced with DTT prior to the run. Lane 1: ESPAg SLM control; 
Lane 2: IgG1 control  undigested; Lanes 3 and 4: IgG1 + Ss ESPAg SLM incubated for 24 h 
at pH 4.5, 27 ºC and 37 ºC; Lanes 5 and 6: IgG1 + Ss ESPAg SLM incubated for 24 h at pH 
5.6, 37 ºC; Lane 7: IgG1 + Ss ESPAg SLM incubated for 24h at pH 5.6, 37 ºC, non reduced; 
Lane 8: IgG2 control undigested; Lanes 9 and 10: IgG2 + Ss ESPAg SLM incubated for 24 h 
at pH 4.5, 27 ºC and 37 ºC; Lane 11:  IgG2 + Ss ESPAg SLM incubated for 24 h at pH 5.6, 
37 ºC; Lane 12: IgG2 + Ss ESPAg SLM incubated for 24 h at pH 7.2, 37 ºC; Lane 13: IgG2 
+ Ss ESPAg SLM incubated 24 h at pH 5.6, 37 ºC, non reduced.  
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yeast in the host. This lapsed time is coincidental with the expression of 
proteolytic activity observed at day two in cultures. 
We also demonstrated that the proteases present in the ESPAg SLM 
were able to interact with immunoglobulins at a pH and temperature 
similar to the ones observed in inflammatory processes, cleaving both 
IgG1 and IgG2 in the microenvironment of the live yeasts, and producing 
polypeptide fragments consistent in molecular weight with Fab and Fc 
(Fig. 4). It will be worth to further study this process that might be of 
importance to explain interference by the fungi of the humoral immune 
response of the host.
In sum, the production of pure viable yeast phase from Sporothrix 
schenckii might help to produce very specific antigenic products and 
eventual detection systems to be used in the proteomics of the fungal 
invasion and survival. 
REsuMo
Produtos da excreção-secreção e proteases da fase leveduriforme 
do Sporothrix schenckii. Detecção imunológica e clivagem de igG 
humana
As preparações antigênicas de Sporothrix schenckii provêm 
geralmente de cultivos mistos de leveduras e micélios e apresentam 
reações cruzadas com outras micoses profundas. Foi padronizada a 
obtenção da fase leveduriforme pura, com alto índice de células viáveis, o 
que permite, por sua vez, obter produtos específicos da excreção-secreção 
sem contaminantes somáticos. Estes produtos da excreção-secreção são 
altamente imunogênicos, e não apresentam reações cruzadas visíveis 
em dupla difusão e sem Western blot. O preparado antigênico consiste 
principalmente em proteínas com peso molecular entre 40 e 70 kDa, 
sendo que algumas apresentam atividade proteolítica em meios levemente 
ácidos.
Foi observada atividade do tipo catepsina em produtos da excreção-
secreção obtidos a partir de leveduras de dois dias de cultivo, e atividade 
do tipo quimiotripsina aos quatro dias de cultivo, consistente com a 
mudança de concentração de proteínas secretadas. As proteases puderam 
clivar diferentes subclasses de IgG humanas, o que sugere uma produção 
seqüencial de antígenos e moléculas que podem interagir com a resposta 
imune do hospedeiro.
REFERENCEs
 1.  ACOSTA, D.; GOÑI, F. & CARMONA, C. - Characterization and partial purification 
of a leucine aminopeptidase from Fasciola hepatica. J. Parasit., 84: 1-7, 1998.
 2. ASAHI, M.; LINDQUIST, R.; FUKUYAMA, K. et al. - Purification and characterization 
of major extracellular proteinases from Trichophytom rubrum. Biochem. J., 232: 
139-144, 1985.
 3.  BERASAIN, P.; CARMONA, C.; FRANGIONE, B.; DALTON, J. P. & GOÑI, F. - 
Fasciola hepatica: parasite-secreted proteinases degrade all human IgG subclasses: 
determination of the specific cleavage sites and identification of the immunoglobulin 
fragments produced. Exp. Parasit., 94: 99-110, 2000.
 4.  BERNARDES-ENGEMANN, A.R.; COSTA, R.C.; MIGUENS, B.R. et al. - 
Development of an enzyme-linked immunoabsorbent assay for the serodiagnosis of 
several clinical forms of sporotrichosis. Med. Mycol., 43: 487- 493, 2005.
 5.  CALICH, V.L.; PURCHIO, A. & PAULA, C.R. - A new fluorescent viability test for 
fungi cells. Mycopathologia (Den Haag), 66: 175-177, 1979.
 6.  CAMARGO, Z.P.; BERZAGHI, R.; AMARAL, C.C. & SILVA S.H. - Simplified 
method for producing Paracoccidioides brasiliensis exoantigens for use in 
immunodiffusion tests. Med. Mycol., 41: 539-542, 2003.
 7.  CARLOS, I.Z.; SGARBI, D.B. & PLACERES, M.C. - Host organism defense 
by a peptide-polysaccharide extracted from the fungus Sporothrix schenckii. 
Mycopathologia (Den Haag), 144: 9-14, 1998/1999. 
 8.  CASTILLO, M.C.; TAPIA, F.J. & ARCINIEGAS, E. - Ultrastructural localization of 
specific surface antigens in the dimorphic fungus Sporothrix schenkii. J. Med. vet. 
Mycol., 28: 91-94, 1990.
 9.  CONTI DIAZ, I.A. - Epidemiology of sporotrichosis in Latin America. Mycopathologia 
(Den Haag), 108: 113-116, 1989.
 10.  DALTON, J.P. & HEFFERNAN, M. - Thiol proteases released in vitro by Fasciola 
hepatica. Mol. Biochem. Parasitol., 35: 161-166, 1989. 
 11.  De ALBORNOZ, M.B.; VILLANUEVA, E. & DE TORRES, E.D. - Application of 
immunoprecipitation techniques to the diagnosis of cutaneous and extracutaneous 
forms of sporotrichosis. Mycopathologia (Den Haag), 85: 177-183, 1984.
 12.  DEEPE, G.S.; GIBBONS, R.; BRUNNER, G.D. & GOMEZ, F.J. - A protective 
domain of heat-shock protein 60 from Histoplasma capsulatum. J. infect. Dis., 174: 
828-834, 1996.
 13.  GOIHMAN-YAHR, M.; PINE, L. & ALBORNOZ, M.C. et al. - Studies on plating 
efficiency and estimation of viability of suspensions of Paracoccidioides brasiliensis 
yeast cells. Mycopathologia (Den Haag), 71: 73-83, 1980.
 14.  HEMPEL, H. & GOODMAN, N.L. - Rapid conversion of Histoplasma capsulatum, 
Blastomyces dermatitidis and Sporothrix schenckii in tissue culture. J. clin. 
Microbiol., 1: 420-424, 1975.
 15.  KAUFFMAN, C.A. - Sporotrichosis. Clin. infect. Dis., 29: 231-236, 1999.
 16.  LAEMMLI, U.K. - Cleavage of structural proteins during the assembly of the head 
of bacteriophage T4. Nature, 227: 680-685, 1970.
 17.  LIMA, O.C. & BEZERRA, L.M. - Identification of a concanavalin A-binding 
antigen of the cell surface of Sporothrix schenckii. J. med. vet. Mycol., 35: 167-172, 
1997. 
Table 1
Specific peptidase activity of ESPAg SLM on different fluorogenic peptides 
performed at 37 ºC in 50 mM citrate pH 4.5. The measurements are expressed 
as µmols of Mec/min/mg. Each measurement is the average of at least three 
determinations
ESPAg SLM
2 days Fluorogenic Peptide 4 days
PBS PBS
103 N-Boc-Val- leu- lys. AMC 101
649 NCBz-Phe- Arg. AMC 97
232 N-succinyl-leu- leu- Val- Tyr.AMC 56
41 N-succinyl-Ala- Ala- Pro- Phe. AMC 498
84 N-succinyl-Gly-Pro-leu-Gly-Pro. AMC 408
49 NCBz-Gly- Gly- Arg. AMC 105
DA ROSA, D.; GEZUELE, E.; CALEGARI, L. & GOÑI, F. - Excretion-secretion products and proteases from live Sporothrix schenckii yeast phase. Immunological detection and cleavage 
of human IgG. Rev. inst. Med. trop. s. Paulo, 51(1): 1-7, 2009.
7
 18.  LIMA, O.C.; FIGUEIREDO, C.C.; PEREIRA, B.A. et al. - Adhesion of the human 
pathogen Sporothrix schenckii to several extracellular matrix proteins. Braz. J. med. 
biol. Res., 32: 651-657, 1999.
 19.  LLOYD, K.O. & BITOON, M.A. - Isolation and purification of a peptido-
rhamnomannan from the yeast form of Sporothrix schenckii. Structural and 
immunochemical studies. J. immunol., 107: 663-671, 1971. 
 20.  LLOYD, K.O. & TRAVASSOS, L.R. - Immunochemical studies on L-rhamno-D-
mannans of Sporothrix schenckii and related fungi by use of rabbit and human antisera. 
Carbohydr. Res., 40: 89-97, 1975.
 21.  MENDOZA, M.; DIAZ, A.M.; HUNG, M.B. et al. - Production of culture filtrates 
of Sporothrix schenckii in diverse culture media. Med. Mycol., 40: 447-454, 2002.
 22.  OUCHTERLONY, O. - Antigen-antibody reactions in gels. Acta path. microbiol. 
scand., 26: 507-515, 1949. 
 23.  POLONELLI, L. & MORACE, G. - Exoantigen studies of Sporothrix schenckii, 
Ceratocystis minor, and Graphium penicillioides cultures. J. clin. Microbiol., 15: 
362-365, 1982.
 24.  RASKA, M.; ZEMANOVA, E.; KAFKOVA, L. et al. - Isolation and characterization 
of an immunogenic fragment of heat shock protein 60 from Trichophyton 
mentagrophytes. Mycoses, 47: 482-490, 2004.
 25  REDINBAUGH, M.G. & TURLEY, R.B. - Adaptation of the bicinchoninic acid protein 
assay for use with microtiter plates and sucrose gradient fractions. Analyt. Biochem., 
153: 267-271, 1986. 
 26.  REED, K.D.; MOORE, F.M.; GEIGER, G.E. & STEMPER, M.E. - Zoonotic 
transmission of sporotrichosis: case report and review. Clin. infect. Dis., 16: 384-
387, 1993.
 27.  SCHUBACH, A.O.; SCHUBACH, T.M. & BARROS, M.B. - Epidemic of cat-
transmitted sporotrichosis. New. Engl. J. Med., 353: 1185-1186, 2005.
 28.  SCOTT, E.N. & MUCHMORE, H.G. - Immunoblot analysis of antibody responses to 
Sporothrix schenckii. J. clin. Microbiol., 27: 300-304, 1989.
 29.  TOWBIN, H.; STAEHELIN, T. & GORDON, J. - Electrophoretic transfer of proteins 
from polyacrilamide gels to nitrocellulose sheets: procedures and some applications. 
Proc. nat. Acad. sci. (wash.), 76: 4350-4354, 1979.
 30.  TSUBOI, R.; SANADA, T.; TAKAMORI, K. & OGAWA, H. - Isolation and properties 
of extracellular proteinases from Sporothrix schenckii. J. Bact., 169: 4104-4109, 
1987.
 31.  TSUOBI, R.; KURITA, Y.; NEGI, M. & OGAWA, H. - A specific inhibitor of 
keratinolytic proteinase from Candida albicans could inhibit the cell growth of C. 
albicans. J. invest. Derm., 85: 438-440, 1985.
 32.  VAITUKAITIS, J.; ROBBINS, J.B.; NIESCHLAG, E. & ROSS, G.T. - A method 
for producing specific antisera with small doses of immunogen. J. clin. Endrocr., 
33: 988-991, 1971.
 33.  YU, R.J.; HARMON, S.R.; GRAPPEL, S.F. & BLANK, F. - Two cell-bound keratinases 
of Trichophyton mentagrophytes. J. invest. Derm., 56: 27-32, 1971.
Received: 26 November 2007
Accepted: 24 November 2008
